New biomarkers in endometriosis

LM Coutinho, MC Ferreira, ALL Rocha… - Advances in clinical …, 2019 - Elsevier
Endometriosis is a benign gynecological disorder which presents significant challenges in
terms of diagnosis and management. Despite decades of research, there are no sufficiently …

Clinical applications of somatostatin receptor (agonist) PET tracers beyond neuroendocrine tumors

R Helgebostad, ME Revheim, K Johnsrud, K Amlie… - Diagnostics, 2022 - mdpi.com
Somatostatin receptor (SSTR) agonist tracers used in nuclear medicine scans are classically
used for neuroendocrine tumor diagnosis and staging. SSTR are however, expressed more …

Relaxed fibronectin: a potential novel target for imaging endometriotic lesions

B Trachsel, S Imobersteg, G Valpreda, G Singer… - EJNMMI research, 2024 - Springer
Background Endometriosis is characterized by the ectopic occurrence of endometrial tissue.
Though considered benign, endometriotic lesions possess tumor-like properties such as …

Endometriosis: recent advances that could accelerate diagnosis and improve care

MJ Griffiths, AW Horne, DA Gibson, N Roberts… - Trends in Molecular …, 2024 - cell.com
Endometriosis is a common disorder associated with pain, gastrointestinal and urinary
symptoms, infertility, and fatigue. It is defined by the presence of endometrial-like lesions …

Noninvasive diagnostic imaging for endometriosis part 2: a systematic review of recent developments in magnetic resonance imaging, nuclear medicine and …

JC Avery, S Knox, A Deslandes, M Leonardi, G Lo… - Fertility and …, 2024 - Elsevier
Endometriosis affects 1 in 9 women, taking 6.4 years to diagnose using conventional
laparoscopy. Non-invasive imaging enables timelier diagnosis, reducing diagnostic delay …

Molecular Imaging in Gynecology: Beyond Cancer

J Sebastiano, C Rodriguez, ZV Samuels… - Journal of Nuclear …, 2024 - jnm.snmjournals.org
Gynecological pathologies account for approximately 4.5% of the overall global disease
burden. Although cancers of the female reproductive system have understandably been the …

Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu] Lu-DOTATATE in a panel of cancer cell lines

W Delbart, GE Ghanem, I Karfis, P Flamen… - Nuclear medicine and …, 2021 - Elsevier
Abstract Introduction [177 Lu] Lu-DOTATATE is an effective systemic targeted radionuclide
therapy for somatostatin receptor (SSTR) positive metastatic or inoperable neuroendocrine …

Positron emission tomography in the evaluation of endometriosis: A systematic review

R Fox, S Chang, L Hicks, S Mooney… - European Journal of …, 2024 - Elsevier
Despite the profound impact of endometriosis worldwide, delays in diagnosis and
suboptimal surveillance techniques are well-recognised issues. Case studies have reported …

The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health

L Evangelista, P Guglielmo, A Pietrzak… - Seminars in Nuclear …, 2024 - Elsevier
This work discusses the role of Nuclear Medicine for women's health, the role of women in
the development of this emerging field and the various issues which arise from both. It …

[HTML][HTML] Somatostatin Receptor PET Imaging of Physiologic and Benign Processes: Implications for Image Interpretation, Avoiding Pitfalls, and Clinical Applications

WY Raynor, JS Kempf - Applied Radiology, 2024 - appliedradiology.com
Purpose: Somatostatin receptors (SSTR) are expressed by neuroendocrine cells in various
organs, including in the spleen, thyroid gland, pituitary gland, and adrenal glands …